Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2012
Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancerLeanne Stevenson, Wendy L Allen, Richard Turkington, et al.
Nanoscale|October 19, 2019
Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumoursWilliam J McDaid, Michelle K Greene, Michael C Johnston, et al.
Cell Communication and Signaling : CCS|November 10, 2018
USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cellsAidan P McCann, Peter Smyth, Francesco Cogo, et al.
Molecular Cancer Therapeutics|October 27, 2011
A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancerWendy L Allen, Leanne Stevenson, Vicky M Coyle, et al.
Molecular Cancer Research : MCR|July 31, 2024
Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis ModulationDaryl Griffin, Robbie Carson, Debbie Moss, et al.
Oncotarget|October 30, 2016
Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancerConor A Bradley, Philip D Dunne, Victoria Bingham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2010
Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancerDonal P McLornan, Helen L Barrett, Robert Cummins, et al.
Oncotarget|July 16, 2014
USP17 is required for clathrin mediated endocytosis of epidermal growth factor receptorJakub Jaworski, Michelle de la Vega, Sarah J Fletcher, et al.
Molecular Oncology|August 24, 2021
Orthogonal MET analysis in a population-representative stage II-III colon cancer cohort: prognostic and potential therapeutic implicationsStephanie G Craig, Svenja Mende, Matthew P Humphries, et al.
Cancer Immunology Research|May 20, 2016
Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant ChemotherapyPhilip D Dunne, Darragh G McArt, Paul G O'Reilly, et al.
Pageof 5